1. Home
  2. ELVN vs CTOS Comparison

ELVN vs CTOS Comparison

Compare ELVN & CTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • CTOS
  • Stock Information
  • Founded
  • ELVN 2016
  • CTOS 1988
  • Country
  • ELVN United States
  • CTOS United States
  • Employees
  • ELVN N/A
  • CTOS N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • CTOS Diversified Commercial Services
  • Sector
  • ELVN Health Care
  • CTOS Consumer Discretionary
  • Exchange
  • ELVN Nasdaq
  • CTOS Nasdaq
  • Market Cap
  • ELVN 1.2B
  • CTOS 1.4B
  • IPO Year
  • ELVN 2020
  • CTOS N/A
  • Fundamental
  • Price
  • ELVN $19.72
  • CTOS $5.72
  • Analyst Decision
  • ELVN Strong Buy
  • CTOS Buy
  • Analyst Count
  • ELVN 5
  • CTOS 3
  • Target Price
  • ELVN $41.20
  • CTOS $6.83
  • AVG Volume (30 Days)
  • ELVN 421.4K
  • CTOS 690.8K
  • Earning Date
  • ELVN 08-13-2025
  • CTOS 10-29-2025
  • Dividend Yield
  • ELVN N/A
  • CTOS N/A
  • EPS Growth
  • ELVN N/A
  • CTOS N/A
  • EPS
  • ELVN N/A
  • CTOS N/A
  • Revenue
  • ELVN N/A
  • CTOS $1,901,675,000.00
  • Revenue This Year
  • ELVN N/A
  • CTOS $13.58
  • Revenue Next Year
  • ELVN $25.00
  • CTOS $5.18
  • P/E Ratio
  • ELVN N/A
  • CTOS N/A
  • Revenue Growth
  • ELVN N/A
  • CTOS 6.21
  • 52 Week Low
  • ELVN $13.30
  • CTOS $3.03
  • 52 Week High
  • ELVN $30.03
  • CTOS $6.64
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 47.40
  • CTOS 45.32
  • Support Level
  • ELVN $18.80
  • CTOS $5.54
  • Resistance Level
  • ELVN $21.30
  • CTOS $5.92
  • Average True Range (ATR)
  • ELVN 0.99
  • CTOS 0.19
  • MACD
  • ELVN -0.06
  • CTOS -0.06
  • Stochastic Oscillator
  • ELVN 36.80
  • CTOS 22.44

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About CTOS Custom Truck One Source Inc.

Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.

Share on Social Networks: